Novel blood test shows promise for early pancreatic cancer detection

German researchers report a blood test capable of detecting pancreatic cancer at earlier, more treatable stages, alongside a new therapeutic drug. The test's sensitivity and specificity remain unquantified in this report, and clinical validation is pending. If confirmed, this could shift pancreatic cancer prognosis, which is currently poor due to late diagnosis.